PEN · Penumbra Inc · Metrics
$320.23
+1.12 (+0.35%)
At close · Nov 18
Return incl. dividend (before tax)
Q3 2025 earnings call transcript
Market Cap
$12.58B
Shares
39.41M
Volume · Nov 18
83.04K
Avg daily vol (3M)
356.3K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
PEN metrics
108 of 125 screener metrics currently available.
Market overview
2 metricsShare price
$319.11
Market cap
$12.58B
Price action
23 metricsPrice change (1W)
-0.7%
Price change (30D)
-1.0%
Price change (3M)
-1.7%
Price change (6M)
-2.3%
Price change (YTD)
+2.6%
Price change (1Y)
+14.6%
Trailing year
Price change (5Y)
+19.7%
52-week high
$359.40
52-week low
$278.10
Change from 52-week high
-11.2%
Change from 52-week low
+14.7%
Annualized volatility
19.5%
Annualized volatility (3M)
7.9%
Implied volatility (30D)
20.8%
IV rank (1Y)
8.8
IV percentile (1Y)
33.8
Beta
0.2
RSI (14D)
44.8
Price vs SMA 50
-0.3%
Price vs SMA 200
-1.9%
Avg volume (3M)
356,297
Relative volume
1.0
Average dollar volume
$114.21M
Company
3 metricsSector
Healthcare
Industry
Medical Devices
Shares outstanding
39.41M
Valuation
12 metricsP / E (TTM)
80.4
Trailing earnings · reciprocal yield 1.2%
PEG ratio
—
EV / revenue
7.6×
reciprocal yield 13.1%
EV / EBITDA
57.0×
reciprocal yield 1.8%
EV / EBIT
63.0×
reciprocal yield 1.6%
P / sales
8.1×
reciprocal yield 12.4%
P / book
7.9
reciprocal yield 12.6%
FCF yield
1.6%
TTM · current market cap
Buyback yield
—
P / FCF
62.8
reciprocal yield 1.6%
P / operating cash flow
48.2
reciprocal yield 2.1%
Earnings yield
1.2%
Historical valuation
8 metricsP / E historical average (3Y)
198.8×
reciprocal yield 0.5%
P / E historical average (5Y)
382.0×
reciprocal yield 0.3%
EV / revenue historical average (3Y)
7.6×
reciprocal yield 13.1%
EV / revenue historical average (5Y)
8.7×
reciprocal yield 11.5%
EV / EBIT historical average (3Y)
604.5×
reciprocal yield 0.2%
EV / EBIT historical average (5Y)
630.9×
reciprocal yield 0.2%
EV / EBITDA historical average (3Y)
167.8×
reciprocal yield 0.6%
EV / EBITDA historical average (5Y)
224.7×
reciprocal yield 0.4%
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-10-29
Profitability
9 metricsGross margin
68.0%
Operating margin
12.1%
Trailing 12 months
Net margin
10.1%
Gross profit (TTM)
$1.06B
Operating profit (TTM)
$189.25M
Net income (TTM)
$157.02M
Trailing 12 months
Diluted EPS (TTM)
$3.97
FCF margin
12.8%
Effective tax rate
24.4%
Growth
11 metricsRevenue growth YoY
+15.6%
Year over year
Net income growth YoY
-7.8%
Revenue (TTM)
$1.56B
Trailing 12 months
EPS growth YoY
-8.5%
Shares change YoY
+0.8%
Year over year · more shares
Revenue CAGR (3Y)
+18.3%
Revenue CAGR (5Y)
+20.2%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
9.9%
Return on assets
7.8%
Debt / equity
0.0
Current ratio
5.9
EBITDA (TTM)
$209.36M
Free cash flow (TTM)
$200.29M
Quick ratio
3.9
Interest coverage
149.6
Net debt / EBITDA
-1.1
Return on invested capital
10.6%
Trailing 12 months
Net cash
$232.88M
Latest balance sheet
Cash & equivalents
$254.28M
Total assets
$2.03B
Total debt
$21.41M
Cash flow & spend
7 metricsOperating cash flow (TTM)
$261.05M
Capital expenditures (TTM)
$60.75M
R&D (TTM)
$94.93M
SG&A (TTM)
$776.61M
Stock compensation (TTM)
$58.40M
R&D / revenue
6.1%
Stock compensation / revenue
3.7%
Ownership (13F)
9 metrics13F filers
432
13F filer change QoQ
-21
Institutional ownership
88.7%
Conviction holders (share of 13F filers)
6.5%
Crowding (high-turnover and private-fund holders)
38.2%
Private-fund adviser ownership
36.2%
Active holders' share change QoQ
+6.8%
Holder tenure
13.0
Price vs estimated holder cost
-1.4%
Ownership (registered funds)
1 metricsIndex-fund ownership
21.3%
Short interest
3 metricsShort interest
6.1%
Latest settlement · 5.3 days to cover
Days to cover
5.3d
Short-squeeze score
64 / 100
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
—
Key facts
CIK
1321732
CUSIP
70975L107
13F (30d)
445 filings
414 filers
Visit website
Investor relations